The short version
4 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
Market view
4 marketed package NDCs · 4 active manufacturers
Most dispensed: 2 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/10mL · Solution · #1 bottle/carton / 118 ml in 1 bottle
4 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
Every detected change for brompheniramine maleate, dextromethorphan hbr, phenylephrine hcl, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.